Literature DB >> 20093234

Differences in clinical significance and morphologic features of Blastocystis sp subtype 3.

Constantine M Vassalos1, Gregory Spanakos, Evdokia Vassalou, Chryssanthy Papadopoulou, Nicholas Vakalis.   

Abstract

Blastocystis is a polymorphic intestinal parasite that is common in humans. A total of 51 asymptomatic and symptomatic patients positive for Blastocystis only were included in the study. Symptoms were mainly nonspecific gastrointestinal symptoms. Blastocystis isolates were xenically cultured and subtyped. Blastocystis species subtype 3 was the predominant subtype. Intrasubtype differences (vacuolar/amoeboid presence) in subtype 3 morphotypes were observed in 32 asymptomatic and symptomatic subtype 3 cases and could possibly be related to Blastocystis pathogenic potential. Diverse morphologic features (vacuolar transiting to amoeboid), probably reflecting the progression from an asymptomatic to a symptomatic state, were observed in an asymptomatic subtype 3 carrier who later had symptoms. Searching for amoeboid forms might be helpful to presumptively screen symptomatic patients with subtype 3 or to follow up an asymptomatic subtype 3 carrier in case symptoms become evident before antiprotozoal treatment was attempted. Further studies on the roles of morphologic features and variation within Blastocystis species subtypes as predictors of symptoms are encouraged.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20093234     DOI: 10.1309/AJCPDOWQSL6E8DMN

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  11 in total

1.  Predominance of Blastocystis sp. subtype 4 in rural communities, Nepal.

Authors:  I L Lee; T C Tan; P C Tan; D R Nanthiney; M K Biraj; K M Surendra; K G Suresh
Journal:  Parasitol Res       Date:  2011-11-11       Impact factor: 2.289

2.  Subtype distribution of Blastocystis isolates identified in a Sydney population and pathogenic potential of Blastocystis.

Authors:  T Roberts; D Stark; J Harkness; J Ellis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-09-21       Impact factor: 3.267

3.  Laboratory diagnosis of Blastocystis spp. in diarrheic patients.

Authors:  Azza S Elghareeb; Mohamed S Younis; Amany F El Fakahany; Ibrahim M Nagaty; Marwa M Nagib
Journal:  Trop Parasitol       Date:  2015 Jan-Jun

4.  Determining intestinal parasitic infections (IPIs) in inmates from Kajang Prison, Selangor, Malaysia for improved prison management.

Authors:  Lorainne Angal; Rohela Mahmud; Sajideh Samin; Nan-Jiun Yap; Romano Ngui; Amirah Amir; Init Ithoi; Adeeba Kamarulzaman; Yvonne A L Lim
Journal:  BMC Infect Dis       Date:  2015-10-29       Impact factor: 3.090

Review 5.  Blastocystis: how do specific diets and human gut microbiota affect its development and pathogenicity?

Authors:  M Lepczyńska; J Białkowska; E Dzika; K Piskorz-Ogórek; J Korycińska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-03-22       Impact factor: 3.267

6.  Resistance towards metronidazole in Blastocystis sp.: A pathogenic consequence.

Authors:  Arutchelvan Rajamanikam; Ho Shiaw Hooi; Madhav Kudva; Chandramathi Samudi; Suresh Kumar
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

7.  Influence of Proton Pump Inhibitors and Histamine Receptor 2 Antagonists on Blastocystis ST3 and Selected Microorganisms of Intestinal Microbiota In Vitro.

Authors:  Małgorzata Lepczyńska; Ewa Dzika; WenChieh Chen; Chien-Yu Lu
Journal:  Clin Transl Gastroenterol       Date:  2021-04-09       Impact factor: 4.396

8.  Blastocystis: Consensus of treatment and controversies.

Authors:  Uma Sekar; M Shanthi
Journal:  Trop Parasitol       Date:  2013-01

9.  Blastocystis: Taxonomy, biology and virulence.

Authors:  Subhash Chandra Parija; Ss Jeremiah
Journal:  Trop Parasitol       Date:  2013-01

10.  Subtype distribution of Blastocystis isolates in Sebha, Libya.

Authors:  Awatif M Abdulsalam; Init Ithoi; Hesham M Al-Mekhlafi; Abdulsalam M Al-Mekhlafi; Abdulhamid Ahmed; Johari Surin
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.